id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FTC-2016-0026-0001,FTC,FTC-2016-0026,"Proposed Consent Agreements: Lupin, Ltd.; Gavis Pharmaceuticals, LLC; and Novel Laboratories, Inc.",Notice,,2016-02-25T05:00:00Z,2016,2,2016-02-25T05:00:00Z,2016-03-23T03:59:59Z,2016-03-01T15:09:16Z,2016-04040,0,0,0900006481e87798